Icova L 0.035mg/0.15mg Tablet
By Icova L
Rx
21 Tablet in a Strip

Composition
Ethinyl Estradiol(0.035mg) + Levonorgestrel(0.15mg)

Manufacturer - Saffron Medicare Pvt Ltd
Distribution Office - #24 Dukheri Road, Mohra District Ambala 133004

Expires on or after
August, 2025

liver
Consult with your doctor for proper guidance before using Icova L 0.035mg/0.15mg Tablet. Limited information is available on the use of this tablet in patients with liver disease. It is important to seek advice from your healthcare provider to ensure the safe and appropriate use of this medication in case of any liver issues.

kidney
Caution should be observed when using Icova L 0.035mg/0.15mg Tablet in patients with kidney disease. Consult your doctor for guidance before use.

alcohol
Caution is recommended when drinking alcohol while taking Icova L 0.035mg/0.15mg Tablet. It is advisable to consult your doctor for guidance.

driving
It is better to consult your doctor. Refrain from driving if you have symptoms impairing focus and reaction time when using Icova L 0.035mg/0.15mg Tablet.

pregnancy
Icova L 0.035mg/0.15mg Tablet is not safe to use during pregnancy. Studies on pregnant women and animals have shown harmful effects to the developing baby. Seek your doctor's advice.

breastfeeding
Icova L 0.035mg/0.15mg Tablet is likely unsafe while breastfeeding. Limited data indicates it may pass into breastmilk and potentially harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | GYNAECOLOGICAL |
Action Class | - |
₹65
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 11-Feb-2025